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Abstract
The demographic and social changes of the past decades have determined improvements in public health and
longevity. So, the number of centenarians is increasing as a worldwide phenomenon. Scientists have focused their
attention on centenarians as optimal model to address the biological mechanisms of “successful and unsuccessful
ageing”. They are equipped to reach the extreme limits of human life span and, most importantly, to show
relatively good health, being able to perform their routine daily life and to escape fatal age-related diseases, such
as cardiovascular diseases and cancer. Thus, particular attention has been centered on their genetic background
and immune system. In this review, we report our data gathered for over 10 years in Sicilian centenarians. Based
on results obtained, we suggest longevity as the result of an optimal performance of immune system and an over-
expression of anti-inflammatory sequence variants of immune/inflammatory genes. However, as well known,
genetic, epigenetic, stochastic and environmental factors seem to have a crucial role in ageing and longevity.
Epigenetics is associated with ageing, as demonstrated in many studies. In particular, ageing is associated with a
global loss of methylation state. Thus, the aim of future studies will be to analyze the weight of epigenetic
changes in ageing and longevity.
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Introduction
Data from centenarian offspring
As well known, life expectancy is a familial trait and
longevity is determined by different factors. In particu-
lar, the environmental milieu and genetic background
play a central role. As demonstrated by many epidemio-
logical studies, family members of long-lived subjects
have a significant survival advantage compared to gen-
eral population. In this context, the study of centenarian
offspring (CO), a group of healthy elderly people with a
familiar history of longevity, might help gerontologists
to better identify the correlation between genetic profile
and hope of a healthy ageing. Previous studies have
reported that CO, like their centenarian parents, have
genetic and immune system advantages, which reflect a
minor risk to develop major age-related diseases, such
as cardiovascular diseases, hypertension or diabetes mel-
litus as well as cancer [1,2]. The lower cardiovascular
disease risk in CO suggests the probability that CO have
some protective factors against atherosclerosis, such as a
good lipid profile. Male CO have higher plasma HDL-C
levels and lower plasma LDL-C levels. Since lipid profile
is directly correlated to atherosclerotic cardiovascular
diseases, this metabolic feature could preserve CO both
to develop these diseases and, as consequence, to reach
a healthy ageing and longer survival [3]. Furthermore,
Rose et al. [4] reported that centenarians and CO show
significantly higher levels of heteroplasmy in mtDNA
control region than controls, a favorable condition for
longevity.
In these last years, some researchers have speculated
about the distinctive immunological profile of offspring
enriched for longevity respect to the immunological fea-
tures of coeval elderly. The cytomegalovirus (CMV) is
one of the most common viruses that affect elderly peo-
ple. Many evidences have shown that CMV infection
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may influence the T cell subset distribution, having an
essential role in immunosenescence [5-7]. CMV infec-
tion is strongly related to both a reduction of CD8
+CD45+CCR7+CD27+CD28+ naïve T cells and to a con-
temporarily increase of CD8+CD45RA-CCR7-CD27-
CD28- late differentiated effector memory and CD45RA-
re-expressing T cells. These parameters are considered
typical of immunosenescence in elderly. Recently, it has
been demonstrated that CMV-seropositive offspring of
long-lived people don’t show the age-associated decrease
of naïve T cells. On the other hand, memory T cell sub-
sets above described do not increase in offspring of
long-lived families, differently from that observed in
age-matched controls [8]. It has been also demonstrated
that CMV-seropositive offspring of long-lived people
have reduced levels of CD8+ T cells expressing CD57
and KLRG1, sometimes referred as “marker of senes-
cence”, when compared to their CMV-infected age-
matched controls. The reduction of effector memory T
cells lacking the expression of CD27 and CD28 and
expressing CD57 and KLRG1, observed in CMV-
infected offspring could explain their high proliferative
response against CMV. The CMV-seropositive offspring
have also shown significantly lower CRP levels com-
pared to their CMV-seropositive age-matched controls
that could be related to a lower pro-inflammatory status
[8].
During ageing, B cell compartment also shows signifi-
cant modifications in numbers and functions [9-12]. In
fact, advanced age is per se a condition characterized by
lack of B clonotypic immune response to new extracellu-
lar pathogens. In any event, data are suggesting that the
loss of naive B cells could represent a hallmark of immu-
nosenescence [13]. On the other hand, a B cell popula-
tion lacking of both IgD and CD27 resulted increased in
healthy elderly [14]. We have suggested that this IgD-
CD27- B cell subset is a population of memory B cells
lacking CD27, a typical memory marker, likely consid-
ered a late memory exhausted B cell subset (Table 1)
[14-16]. This population resulted also increased in active
Lupus patients [17], in healthy subjects challenged with
respiratory syncitial virus [18], and in HIV patients [19].
CO don’t show the typical naïve/memory B cell shift
observed in elderly. Although a decreased B cell count
was observed in CO and their age-matched controls, it
has been demonstrated that naïve B cells (IgD+CD27-)
were more abundant and DN B cells (IgD-CD27-) were
significantly decreased, as looked similarly in young peo-
ple [20]. This B cells distribution in CO could suggest
that antigenic load or inflammatory environment play a
central role in exhaustion of the B cell branch. It is well
documented that the quality and the size of the humoral
immune response declines with age [15,21-26]. This
change is characterized by lower antibody responses and
decreased production of high affinity antibodies. The eva-
luation of IgM secreted in CO serum shows that the
values are within the range of the levels observed in
young subjects [20]. In this way, CO could have a bigger
advantage to fight against new infections and appropri-
ately respond to vaccinations, giving them a selective
advantage for longevity in healthiness.
In conclusion, individuals genetically enriched for
longevity possess immune different signatures respect to
those of the general population (Table 2). This suggests
the idea of the “familiar youth” of the immune system.
In addition, the lower pro-inflammatory status in CMV-
infected offspring of long-lived people might represent
an optimal advantage for healthy longevity and against
mortality associated to major age-related diseases.
Gender and longevity
A characteristic enigma of longevity is the gender and
the social phenomenon of “feminization of old age“. The
demographic and social changes of the past decades,
responsible for longevity and the improvements in pub-
lic health, have created new and often very dissimilar
realties for women and men. People are all aware that
they differ in their anatomy and physiology, but also in
more complex traits, such as lifespan (in Italy, 78.8
years for men and 84.1 years for women, respectively)
and mortality [27-29]. No conclusive explanation for
these new differences is actually demonstrated. An intri-
cate interaction between environmental, social struc-
tural, behavioural (i.e. the complex pattern of roles and
values that define what is thought as masculine and fem-
inine) and genetic factors have been suggested as the
more probable reason [30-32].
From a genetic prospective, our suggestion based on
the studies in Sicilian population supports a female-spe-
cific gene-longevity association, by emphasizing the
paradoxical role of socio-cultural habits in female long-
evity [33]. This concerns the HFE gene, the most telo-
meric HLA class I gene, codifying for a class I a chain,
the HFE protein, which seemingly no longer participates
Table 1 Main modifications of B cells and B cells
products in elderly human observed in our laboratory
B cells or B cells products Changes References
Total B cells (percentage) ↓ [9]
CD19+CD5+ B1 cells (percentage and absolute
number)
↓ [10]
IgG, IgA ↑ [11]
IgM, IgD ↓ [11]
IgE = [11]
Autoantibodies ↑ [12]
Naive (IgD+CD27-) ↓ [13]
DN (IgD-CD27-) ↑ [14-16]
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in immunity. It has lost its ability to bind peptides due
to a definitive closure of the antigen binding cleft that
prevents peptide binding and presentation. The HFE
protein, expressed on crypt enterocytes of the duode-
num, regulates the iron uptake by intestinal cells, having
acquired the ability to form complex with the receptor
for iron-binding transferring. Mutations in HFE gene
are associated with hereditary hemochromatosis, a disor-
der caused by excessive iron uptake [34,35]. Three com-
mon mutations, C282Y, H63D and S65C, have been
identified in HFE gene. In particular, the C282Y muta-
tion (a cysteine-to-tyrosine mutation at amino acid 282)
destroys its ability to make up a heterodimer with b2-
microglobulin. The defective HFE protein fails to associ-
ate to the transferring receptor, and the complex cannot
be transported to the surface of the duodenal crypt
cells. As a consequence, in homozygous people, two to
three times the normal amount of iron is absorbed from
food by the intestine, resulting in end-organ damage
and reducing lifespan. Two other mutations, H63D (a
histidine to aspartate at amino acid 63) and S65C (a ser-
ine to cysteine at amino acid 65), are associated with
milder forms of this disease [34,35].
An association between C282Y mutation and longevity
characterizes the Sicilian population studied [33]. In par-
ticular, women carriers of C282Y mutation had a higher
frequency among the oldest old compared to control
women (Table 3). Thus, the C282Y mutation may confer
a selective advantage in terms of longevity in Sicilian
women. Considering the historical and social context in
which the generation of women under study lived, our
data seem to propose that the possession of iron-sparing
alleles significantly increases the possibility for women to
reach longevity. For instance, in Sicily, many pregnancies
and an iron-poor diet, consisting mainly in grains, vege-
tables, and fruits, were still the rule for women born at
the beginning of last century. In fact, meat was available
for men but not for women; this clearly explains how
genetic background also interacts with culture habits
[30,31,33].
Our data, showing the relevance of C282Y for women
survival to late age, allow adding another piece of evi-
dence to the complex puzzle of genetic and environmen-
tal factors involved in control of lifespan in humans. The
complex interaction of environmental, historical and
genetic factors, differently characterizing the various
parts of a country, i.e. Italy, likely plays an important role
in determining the gender-specific probability of attain-
ing longevity [30,31,33,36].
Role of innate immunity genes in longevity: the
paradigmatic case of TLR4, CCR5, COX-2 and 5-LO genes
According to evolutionary ageing theories, most of the
parameters influencing immunosenescence appear to be
under genetic control [32,37,38]. An example is given by
the innate immune system, involved in neutralizing infec-
tious agents [39]. It plays a beneficial role until the time
of reproduction and parental care. In old age, a period
largely not foreseen by evolution, it can determine an
opposite and detrimental effect through chronic inflam-
matory responses (“antagonistic pleiotropy”) [38,40].
Genetic pro-/anti-inflammatory variations in innate
immune response are, indeed, thought to influence the
susceptibility of age-related human diseases, by altering
host response to environmental and endogenous stress
[41]. Thus, they are able to determine a negative or posi-
tive control of inflammation, by affecting both interac-
tions between host and microbes and survival of the
individual and attainment of longevity. Furthermore, they
appear both to be responsible, at least in large part, for
different men and women strategies to achieve longevity,
and to contribute to the preferential sex dimorphism of
the age-related diseases [30,31,33].
From our investigations in Sicilian population, TLR4,
CCR5, Cox2, 5-Lo genes can be considered good exam-
ples. They provide an ideal model to understand the dif-
ferent implications of their genetic variants in the risk of
age-related diseases, i.e. atherosclerosis and prostate
cancer (PC), and reciprocally in increased chance to
attain longevity.
TLR4 gene (number accession of GenBank: NM-
138554.1) codifies the best understood TLR member
involved in recognition of LPS, the prototypic TLR4
ligand, and other exogenous and endogenous (i.e. HSPs,
hyaluronic acid, b-defensin-2, ox-LDL, fibronectin and
amyloid peptide) ligands. TLR4 activation implies a down-
stream signaling mediated by several intracellular adaptor
molecules and the consequent activation of transcription
Table 2 Cellular and humoral immune modification in offspring from longevity families compared to their AM controls
T and B cell Phenotypes and Products Changes References
Naïve T cells (CD3+CD8+CD45RA+CCR7+CD27+CD28+) Increase [8]
Late differentiated effector memory T cells (CD3+CD8+CD45RA-CCR7-CD27-CD28-) Decrease [8]
TEMRA (CD3+CD8+CD45RA+CCR7-CD27-CD28-) Decrease [8]
Naïve B cells (IgD+CD27-) Increase [20]
Double Negative B cells (IgG+/IgA+IgD-CD27-) Decrease [20]
Serum IgM Increase [20]
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factors, such as NF-kB. This determines the production of
different pro/anti-inflammatory mediators. These lasts,
such as IL-10, are produced by the parallel activation of
anti-inflammatory pathways to limit the potential tissue
damage from excessive activation of the innate immune
system [42]. SNPs seem to modulate both TLR4 activity
and function. In human, only two SNPs, +896A/G
(Asp299Gly; rs4986790) and +1196 C/T (Thr399Ile;
rs4986791), have a frequency > 5%. They induce a blunted
response to LPS, as first suggested by Arbour et al., and
are phenotypically associated to changes in the production
of cytokines, principally those carrying the Asp299Gly
mutation [43-45]. Accordingly, recent literature data sug-
gest the ability of this SNP to modulate the risk of major
age-related diseases [42].
The CCR5 gene (number accession of GenBank: NM-
00579) codifies for a G protein-coupled chemokine
receptor, which regulates trafficking and effector func-
tions of memory/effector Th1 cells, macrophages, NK
cells and immature dendritic cells. CCR5 and its ligands
are important molecules in viral pathogenesis. Recent
evidence has also demonstrated the role of CCR5 in a
variety of human diseases, ranging from infectious and
inflammatory age-related diseases to cancer. A notable
variant of CCR5 gene is a 32 bp (Δ32) deletion, which
causes a frame shift mutation in exon 4 (CCR5Δ32;
rs333) and determines stop protein maturation and loss
of expression of functional CCR5 receptor [46]. Accord-
ingly, it seems to have a protective role against CVD
and other age-related diseases, such as PC. It, indeed,
Table 3 Data from our investigations in Sicilian population
Gene Alleles of genetic variants Centenarians Young controls (< 55 years) P
N = 35 females N = 106 females
HFE C282 47 (84%) 132 (0%) 8.3 × 10-5 [33]
282Y 9 (16%) 0 (0%)
Genes Alleles of SNPs or genetic variants Centenarians Young controls (< 55 years) MI patients (< 55 years) P
N = 55 males N = 127 males N = 105 males
TLR4 +896A 94 (85.4%) 239 (94.1%) 205 (97.6%) < 0.001 [49]
+896 G 16 (14.6%) 15 (5.9%) 5 (2.4%)
N = 123 males N = 136 males N = 133 males
CCR5 WT 221(89.8%) 252 (92.6%) 263 (98.8%) 0.00006 [48]
Δ32 25 (10.2%) 20 (7.4%) 3 (1.2%)
N = 96 males N = 170 males N = 140 males
Cox-2 -765 G 122 (63.5%) 240 (70.6%) 232(82.8%) 0.000007 [47]
-765 C 70(36.5%) 100(29.4%) 48(17.2%)
5-Lo -1708 G 180 (93.7%) 302(88.8%) 224(80%) 0.00003 [47]
-1708A 12(6.3%) 38(11.2%) 56(20%) 0.001
21 C 176(91.7%) 299(88%) 225(80.4%)
21 T 16(8.3%) 41(12%) 55(19.6%)
Genes Alleles of SNPs or genetic variants Centenarians Young controls (< 55 years) PC patients (< 55 years) P
N = 55 males N = 125 males N = 50 males
TLR4 +896A 94 (85%) 235 (94%) 99 (99%) 0.001 [54]
+896 G 16 (15%) 15 (6%) 1 (1%)
Cox-2 -765 G 67 (61%) 176 (70%) 77 (77%) 0.05
5-Lo -765 C 43 (39%) 74 (30%) 23(23%) 0.0007
-1708 G 104 (95%) 223 (89%) 77 (77%)
-1708A 6 (5%) 27 (11%) 23 (23%)
N = 53 males N = 50 males
CCR5 WT 95 (89.6%) 97 (97%) 0.03 [53]
Δ32 11(10.4%) 3(3%)
Gene Alleles of SNPs or genetic variants Centenarians Young controls (< 55 years) BF patients (30-60 years) P
N = 42 females N = 42 females N = 42 females
TLR4 +896A 81 (96.4%) 78 (92.9%) 76 (90.4%) 0.003 [55]
+ 896 G 3 (3.6%) 6 (7.1%) 8 (9.6%)
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determines a slower progression of atherogenesis or
cancerogenesis as a consequence of an attenuated
inflammatory response.
COX-2 gene maps in the 1q25 chromosome and codifies
for the Cox-2 enzyme involved in the conversion of ara-
chidonic acid to prostaglandins. Polymorphisms regulate
its expression and hence prostanoid biosynthesis. In parti-
cular, it has been identified a guanine to cytosine substitu-
tion at position -765 G/C, located within a putative
binding site for the transcription factor Sp1, associated to
a reduction in the risk of clinical cardiovascular events.
COX-2 is expressed at low levels in most tissues, but its
expression enhances under inflammatory stimuli and in
inflammatory age-related processes, i.e. atherosclerosis,
rheumatoid diseases and cancer [47].
The 5-LO gene maps in the chromosome 10q11.2 and
codifies the 5-Lo enzyme involved in the synthesis of LTs.
The 5-LO pathway has been associated to atherosclerosis
in mouse and human histological studies. Several SNPs
have been described. In particular, the - 1708 G/A, -1761
G/A and 21 C/T SNPs in promoter region and exon-1 of
5-LO gene modify the gene transcription or the putative
protein [47].
An over-expression of anti-inflammatory CCR5Δ32
variant, +896 G (299Gly) TLR4 allele, -765 C Cox-2
allele, -1708 G and 21 C 5-Lo alleles characterizes male
Sicilian centenarians (Table 3) [47-49]. So, male cente-
narians are people who seem genetically equipped for
defeating major age-related diseases. They present SNPs
in the immune system genome (i.e. SNPs or other genetic
variations, located within the promoter regions of pro-
inflammatory cytokines) which, regulating the immune-
inflammatory responses, seem to be associated to longev-
ity [30-32]. Furthermore, centenarians are characterized
by marked delay or escape from age-associated diseases,
responsible for the high mortality in earlier ages. In parti-
cular, it has been demonstrated that centenarian off-
spring have an increased likelihood of surviving to 100
years and show a reduced prevalence of age associated
diseases, such as CVD, and lower prevalence of CVD risk
factors [1,30-32,50] Thus, genes involved in CVD may
play an opposite role in human male longevity. Our data
in male Sicilian population confirm this suggestion and
emphasize the role of antagonistic pleiotropy in ageing
and longevity [51,52]. A high frequency of proinflamma-
tory CCR5wt variant, +896A TLR4 allele, -765 G Cox-2
allele, 1708A and 21 T 5-Lo alleles characterizes male
Sicilian patients affected by MI (Table 3) [47-49]. In a
recent study, we also found a similar overexpression of
these proinflammatory SNPs in male Sicilian patients
affected by PC (Table 3). Opposite data were obtained in
male centenarians [53,54].
In contrast, female Sicilian centenarians have a differ-
ent frequency of the alleles of +896A/G TLR4 SNP than
that observed in male Sicilian centenarians. In particu-
lar, female Sicilian centenarians show an over-expression
of the pro-inflammatory +896A TLR4 allele respect to
female patients affected by Boutonneuse fever and age-
matched controls (Table 3) [55].
On the other hand, pro-inflammatory responses are
evolutionary programmed to resist fatal infections. Thus,
it is not surprising that the genetic background of peo-
ple that survive to an advanced age may be protective
against infections [55].
Based on our data, we suggest that Sicilian men and
women may follow different trajectories to reach longev-
ity. For men it might be more important to control
atherogenesis and cancerogenesis, whereas for women it
might be more important to control infectious diseases
[30,31].
In order to confirm our suggestions on the biological
effects of +896A/G TLR4 SNP and its role in the patho-
physiology of age-related diseases studied (i.e. MI and
PC) and longevity, we recently assessed the levels of IL-6,
TNF-a, IL-10 and eicosanoids in LPS-stimulated whole
blood samples from 50 young healthy Sicilians, screened
for the presence of this SNP. Both pro-inflammatory
cytokines and eicosanoids were significantly lower in car-
riers bearing the +896 G TLR4 allele, whereas the anti-
inflammatory IL-10 values were higher [56]. This sug-
gests the ability of the +896 G TLR4 allele to mediate a
better control of inflammatory responses induced by
chronic stimuli, so likely decreasing the effects of athero-
genetic damage and prostate carcinogens.
On the basis of data reported herein, some suggestions
can be drawn. First, pathogen load, by interacting with the
host genotype, determines the type and intensity of inflam-
matory responses, according to the pro-inflammatory
status and tissue injury, implicated in the patho-physiology
of major age-related diseases. Second, adequate control of
inflammatory response might reduce the risk of these
diseases, and, reciprocally, might increase the chance of
extended survival in an environment with reduced patho-
gen load. Accordingly, a higher frequency of the anti-
inflammatory +896 G TLR4 allele has been observed in
centenarians [49].
Cytokine profile: a biomarker for successful ageing
Cytokines are considered key players in maintaining lym-
phocyte homeostasis [57,58]. Their function is not lim-
ited to induce response after an immune insult, but they
can modulate the nature of response (cytotoxic, humoral,
cell mediated, inflammatory or allergic) or, in contrast,
they may cause non-responsiveness and active immune
suppression [58]. Furthermore, sequence variations in
several cytokine genes, such as IFN-g and IL-10 genes,
have been demonstrated to be associated with successful
ageing and longevity [58]. On the other hand, individual
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changes in type and intensity of immune response affect-
ing life span expectancy and health ageing seem to have a
genetic component. A well-preserved immune function
characterizing the successful ageing has been found in
centenarians [38]. Recent evidence suggests that cente-
narians seem to be genetically equipped gene polymorph-
ism for overcame the major age-related diseases and
polymorphisms in immune system genes involved in reg-
ulation of immune responses have been found associated
to longevity. In particular, associations between both
cytokine gene polymorphisms and longevity, and differ-
ential gender longevity in males and females, and recipro-
cally to age-related diseases have been demonstrated
[38,58,59].
Our data in Sicilian population confirm these associa-
tions and suggest that differences in the genetic regula-
tion of immune inflammatory processes might explain
the reason why some people but not others develop
age-related diseases and why some develop a greater
inflammatory response than others. In particular, this
suggestion seems to be suitable for some SNPs in IFN-g
and IL-10 genes (Table 4) [60-63].
IFN-g gene codifies for a cytokine involved in defense
against viruses and intracellular pathogens, and in
induction of immune mediated inflammatory responses.
Its production is genetically regulated. A variable length
CA repeat sequence in the first intron of IFN-g gene has
been described to be associated with high IFN-g produc-
tion. Furthermore, a SNP, T to A (+874 T/A), at 59 end
of the CA repeat region has been described and T pre-
sence has been related to high-producing microsatellite
allele 2. This SNP coincides with a putative NF-B
binding site, which might have functional consequences
for transcription of IFN-g gene. Thus, this SNP might
directly influence IFN-g production levels associated to
CA microsatellite marker [60].
IL-10 gene codifies for IL-10 cytokine. IL-10 is pro-
duced by macrophages, T and B cells. It is one of the
major immune-regulatory cytokines, usually considered
to mediate potent down-regulation of inflammatory
responses. IL-10 production, independently on interac-
tion with other cytokine gene products, is generally con-
trolled by several polymorphic elements in the 5’ flanking
region of IL-10 gene. Multiple SNPs have been identified
in human IL-10 5’ flanking region and some of these (i.e.
-592, -819, -1082) combine with microsatellite alleles to
form haplotype associated with differential IL-10 produc-
tion. These three SNPs in the IL-10 proximal gene region
(considered potential targets for transcription regulating
factors) might be involved in genetic control of IL-10
production, even if contrasting literature data have been
reported. In particular, the homozygous -1082GG geno-
type seems to be associated with higher IL-10 production
respect to G/A heterozygous and AA homozygous geno-
types. Furthermore, this SNP seems to be functionally
relevant. It has been demonstrated that -1082 A carriers
(low producers) seem likely develop a major number of
chronic inflammatory diseases [61-63].
Our results demonstrated an increase of subjects carry-
ing the -1082 G IL-10 allele in centenarian men [61-63].
This allele is associated to significantly increased IL-10
production. Conversely, we observed that the frequency
of -1082A allele, associated to low IL-10 production, was
significantly higher in MI patients (Table 4) [63]. Thus,
Table 4 Cytokine data from our studies in Sicilian population
Gene Genotypes Centenarians Young controls (< 55 years) P
N = 31 males N = 161 males
IL-10 -1082GG 18 (58%) 55 (34%) < 0.025 [61]
-1083GA 9 (29%) 88 (55%)
-1082AA 4 (13%) 18 (11%)
N = 72 males N = 115 males
IL-10 -1082GG 33 (46%) 32(28%) 0.019 [62]
-1083GA 34(47%) 64(56%)
-1082AA 5(7%) 19(16%)
Centenarians Young controls (< 55 years) MI patients (< 55 years) P
N = 52 males N = 110 males N = 90 males
IL-10 -1082GG 25 (48.1%) 26(23.6%) 17 (18.9%) 0.003 [63]
-1083GA 23 (44.2%) 56 (50.9%) 29 (32.2%)
-1082AA 6(11.5%) 28 (25.5%) 44 (48.9%)
Genes Alleles of SNP Centenarians Young controls (< 55 years) P
N = 142 females N = 90 females
IFN-g +874 T 102 (35.9%) 85 (47.2%) 0.02 [60]
+ 874A 182 (64.1%) 95 (52.8%)
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high IL-10 production seems to be protective vs. MI and
a possible biomarker for longevity. People with excep-
tional longevity have genetic factors (i.e. protective fac-
tors for CVD) that modulate ageing processes [63]. This
supports the opinion that a genetic background protec-
tive against CVD is a component of longevity. On the
other hand, our immune system has evolved to control
pathogens and pro-inflammatory responses are likely
programmed by evolution to resist fatal infections. From
this prospective, low IL-10 production is correlated with
increased resistance to pathogens. In older ages not evo-
lutionally programmed, increased IL-10 levels might bet-
ter control inflammatory responses induced by chronic
vessel damage and reduce the risk for atherogenetic com-
plications. These conditions might permit to achieve
exceptional ages in an environmental with a reduced
pathogen load [63].
In contrast, female Sicilian centenarians are character-
ized by an over-expression of +874 INF-g allele (Table 4)
[60]. The INF-g production is also influenced by hormo-
nal control fundamentally mediated by 17b extradiol.
Hormonal regulation of this cytokine has been suggested
to modulate, in part, the ability of estrogens to potentiate
many types of immune responses and to influence the
disproportionate susceptibility of women for immune-
inflammatory diseases. Thus, gene variants representing
genetic advantage for one gender might not be recipro-
cally relevant for the other gender in terms of successful
or unsuccessful ageing [60].
The data from Sicilian investigation add another piece
to complex puzzle of genetic and environmental factors
involved in the control of life span expectancy in humans.
Studies on cytokine gene SNPs may promise to individu-
ate a complex network of trans-inactive genes able to
influence the type and strength of immune responses to
environmental stressors, and as final result, conditioning
individual life expectancy [60-63]. On the other hand, we
recently suggested the possibility to use cytokine profile
as biomarker of successful ageing, by evaluating through
Lumines technology cytokine serum levels in 44 Sicilian
nonagenarians and 79 control subjects (aged between 30
and 50 years old) [64]. IFN-g and IL-2 levels are unmodi-
fied, suggesting a substantial maintenance of relevant T
functions. In addition, a significant increase of IL-12
serum levels was observed. This condition might be asso-
ciated with the increase of NK cell function with ageing.
Furthermore, an increase of IL-13 and a reduction of IL-
4 were found. Thus, the maintenance of some effector’s
mechanisms of immune-response characterizes advanced
ages. From a general point of view, our data firstly con-
firm the age-related remodeling of cytokine network.
Furthermore, they underline the presence of unchanged
levels of some crucial cytokines useful in preserving key
immune function in long-living persons [64].
Future perspectives
The ageing process and longevity are multi-factorial
events. Genetic, epigenetic, stochastic and environmental
factors seem to have a crucial role in ageing and longevity.
Epigenetic is associated to ageing, as shown in the major
number of studies. In particular, ageing is associated to a
global loss of methylation state [65]. In addition, tissue-
dependent age-related hypermetylation of specific DNA
regions have been observed. Thus, it can be concluded
that epigenetic age-related modification are stochastic and
no linked to specific DNA region, while epigenetic
changes linked to specific environmental stimuli are lim-
ited in specific DNA region [66,67]. These observations
have led to address the research on epigenomics and its
implication in ageing and longevity.
Epigenomics is the systematic study of the global gene
expression changes due to epigenetic processes, but not to
DNA base sequence changes. Epigenetic processes consist
in heritable modification that result in a selective gene
expression or repression and consequently in phenotype
changes [68]. These changes include nucleosome position-
ing, post-translation histone modifications, action of small
RNAs, DNA replication timing, heterochromatinization
and DNA methylation [69]. This last one consists in the
addition of a methyl group (-CH3) in the carbon 5 of cyto-
sines, particularly in the CpG dinucleotide. This condition
particularly concerns the CpG islands (CpGIs), located at
the regulatory site of gene promoter regions. Methylation
rate is associated to transcriptional regulation. In particular,
gene silencing is associated to increase of -CH3 groups on
DNA, conversely hypometylation of CGIs is associated to
an open chromatin state resulting in gene expression [70].
Although the association between ageing and epige-
netic is a real evidence, processes involved are not clear.
Certainly, the nutrition affects epigenetic modifications.
Nutrients can be active on specific sites. For example,
vitamin B12, vitamin B6, riboflavin, methionine, choline
and betaine, well known as folates, regulate levels of
S-adenosylmethionine and S-adenosylhomocysteine,
donor of -CH3 group and methyltransferase inhibitor
respectively [71]. Curcumin, resveratrol, polyphenols and
flavonoids, phytoestrogen, and lycopene are also consid-
ered key nutritional factors both for regulation of enzyme
involved in acetylation and deacetylation mechanism and
for one-carbon metabolism [71,72]. A diet rich in vegeta-
bles and fruit, such as Mediterranean diet, may contain
these nutrients. Sicilian centenarians are characterized to
observe this kind of diet, as we reported [73]. Since
genetic and environmental factors contribute to longev-
ity, it may suggest that epigenetic events associated to the
modifications diet-induced are very important for suc-
cessful ageing processes. Furthermore, several literature
data reported a possible link between epigenetic and sev-
eral age-related diseases, such as cancer, metabolic
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syndrome, diabetes and neurodegenerative disorders.
Stable propagation of gene expression from cell to cell
during disease pathogenesis is regulated by epigenetic
mechanisms. For example, during the diabetes onset epi-
genetic changes act on insulin and insulin metabolism
regulating the gene coding [74]. In particular, a recent
study has demonstrated that human insulin gene and
mouse insulin 2 gene expression are under control of epi-
genetic changes in CpGIs. Insulin non expressing cells
are, indeed, methylated in the promoter region of insulin
coding gene, while insulin expressing cells are completely
demethylated in the same site resulting in insulin gene
expression [75]. Another study on monozygotic twin has
demonstrated that insulin resistance is also under control
of DNA methylation [76]. Alterations in insulin pathway
are known to be involved in metabolic disease, such as
metabolic syndrome, insulin resistance and type 2 dia-
betes. Recent data also support the existence of a correla-
tion between these alterations and Alzheimer’s disease.
In the light of these observations, the purpose of our
future studies will be to evaluate the weight of epigenetic
changes in ageing and longevity, using centenarians as
super-controls.
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